Cargando…
Immune checkpoint inhibitor-related hypogonadism and infertility: a neglected issue in immuno-oncology
Despite a significant amount of data on incidence and therapy of immune-related adverse events affecting virtually all organ systems, the potential impact of immune checkpoint inhibitors (ICIs) on gonadal function has not been sufficiently studied. The limited evidence available suggests that ICI-re...
Autor principal: | Özdemir, Berna C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887354/ https://www.ncbi.nlm.nih.gov/pubmed/33589529 http://dx.doi.org/10.1136/jitc-2020-002220 |
Ejemplares similares
-
Gene expression profiles (GEPs) of immuno-oncologic pathways as predictors of response to checkpoint inhibitors in advanced NSCLC
por: De Marchi, Pedro, et al.
Publicado: (2023) -
Lessons From the Development of the Immune Checkpoint Inhibitors in
Oncology
por: Jardim, Denis L., et al.
Publicado: (2018) -
Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development
por: Tawbi, Hussein A, et al.
Publicado: (2023) -
Immune checkpoint inhibitors break whose heart? Perspectives from cardio-immuno-oncology
por: He, Yingying, et al.
Publicado: (2023) -
Immune checkpoint inhibitor-related acral vasculitis
por: Comont, Thibault, et al.
Publicado: (2018)